Katsarelias Dimitrios, Båth John, Carlson Per, Mattsson Jan, Olofsson Bagge Roger
Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
J Surg Case Rep. 2019 Apr 3;2019(4):rjz090. doi: 10.1093/jscr/rjz090. eCollection 2019 Apr.
Isolated limb perfusion (ILP) is used for melanoma in-transit metastases of the extremities. The use of Melphalan and TNF-alpha, necessitates monitoring of possible systemic leakage throughout the perfusion. It has been suspected that leakage through bone marrow is possible. We present the case of a patient with in-transit melanoma metastases in the lower extremity, who underwent minimally invasive ILP, according to our new protocol through percutaneous insertion of the catheters under fluoroscopy. Following cannulation of the vessels a high leakage rate was recorded. The procedure was converted to open with clamping of the artery and vein, however the leakage was not possible to control, and venography showed that this was due to bone marrow veins. To the best of our knowledge this is the first case of a verified leakage during ILP through bone marrow veins. We believe that some minor leakages registered under ILP could be attributed to this leakage route.
孤立肢体灌注(ILP)用于治疗四肢黑色素瘤的移行转移。使用美法仑和肿瘤坏死因子-α时,需要在整个灌注过程中监测可能的全身渗漏情况。一直有人怀疑可能会通过骨髓发生渗漏。我们报告了一例下肢存在移行性黑色素瘤转移的患者,该患者根据我们的新方案,在荧光透视引导下经皮插入导管,接受了微创ILP。血管插管后记录到较高的渗漏率。该手术转为开放手术,夹闭动脉和静脉,但渗漏无法控制,静脉造影显示这是由于骨髓静脉所致。据我们所知,这是首例经证实的ILP过程中通过骨髓静脉发生渗漏的病例。我们认为,ILP过程中记录到的一些轻微渗漏可能归因于这一渗漏途径。